TC Biopharm - חוב לטווח קצר של החברה TCBP

The TC Biopharm (TCBP) production cycle relies on strict scheduling of sterile bio-workshops and regular equipment upgrades. TC Biopharm (TCBP) possesses significant pricing power due to its unique T-cell platform, which is indispensable for oncology patients. This chart of trading on GURU.Markets, where the metric stands at 0.00, highlights the risks of the scientific race and the probability of competitors developing more advanced treatment methods.

This indicator aggregates obligations with maturities of up to one year, allowing for an assessment of current liquidity and the capital structure's sensitivity to interest rate volatility. By analyzing the dynamics of short-term debt, an investor can weigh borrowing costs against the significant pricing power of TC Biopharm (TCBP) within the inelastic demand market for cell therapy, thereby determining the business's resilience to financial risks.